Ventyx Biosciences Drops 3%, Stockholders to Sell ~11.17M Shares
Seeking AlphaApr 10 04:06 ET
Ventyx Biosciences CBO Christopher Krueger Steps Down
TipRanksApr 5 17:22 ET
Kura Sushi Posts Upbeat Sales, Joins Caribou Biosciences, Krispy Kreme And Other Big Stocks Moving Higher In Friday's Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining by around 100 points on Friday. Shares of Kura Sushi USA, Inc. (NASDAQ:KRUS) climbed 6% to $110.11 in pre-market trading foll
BenzingaApr 5 08:01 ET
Ventyx Biosciences (VTYX) Gets a Buy From LifeSci Capital
TipRanksApr 1 10:05 ET
Express News | Canaccord Genuity Maintains Buy on Ventyx Biosciences, Lowers Price Target to $15
Moomoo 24/7Mar 13 10:15 ET
Ventyx Biosciences Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/13/2024 77.41% Canaccord Genuity $16 → $15 Maintains Buy 03/12/2024 41.93% Oppenheimer → $12 Upgrades P
BenzingaMar 13 10:14 ET
Buy Rating Affirmed for Ventyx Biosciences on Strong Clinical Pipeline and Promising Drug Developments
TipRanksMar 13 07:06 ET
Ventyx Biosciences Shares Rise After Oppenheimer, Wells Fargo Upgrades
Ventyx Biosciences (VTYX) shares were up about 5% in recent Tuesday trading after Oppenheimer and Wells Fargo upgraded their ratings for the clinical-stage biopharmaceutical company. Oppenheimer upgra
MT NewswiresMar 12 14:33 ET
Ventyx Rebounds as Oppenheimer Upgrades After Pipeline Updates
Seeking AlphaMar 12 08:27 ET
Today's Morning Movers and Top Ratings: ORCL, CVNA, MSTR, AAL and More
Shares of MicroStrategy surged 6.2% amid optimistic commentary from Wall Street analysts and raised price targets from Canaccord Genuity and TD Cowen.
Movers and ShakersMar 12 08:17 ET · Movers
Express News | Ventyx Biosciences Shares Are Trading Higher After Oppenheimer Upgraded the Stock From Perform to Outperform and Announced a $12 Price Target. Also, Wells Fargo Upgraded the Stock From Equal-Weight to Overweight and Raised Its Price Target From $7 to $16
Moomoo 24/7Mar 12 07:48 ET
Buy Rating Affirmed: Ventyx Biosciences' Promising Clinical Advances and Strategic Position for Market Opportunities
TipRanksMar 12 07:16 ET
Ventyx Biosciences Price Target Raised to $16.00/Share From $7.00 by Wells Fargo
Ventyx Biosciences Price Target Raised to $16.00/Share From $7.00 by Wells Fargo
Dow JonesMar 12 07:09 ET
Ventyx Biosciences (VTYX) Receives a New Rating From Piper Sandler
TipRanksMar 12 06:35 ET
Ventyx Biosciences Raised to Outperform From Perform by Oppenheimer
Ventyx Biosciences Raised to Outperform From Perform by Oppenheimer
Dow JonesMar 12 05:07 ET
Oppenheimer Upgrades Ventyx Biosciences to Outperform, Announces $12 Price Target
Oppenheimer analyst Jeff Jones upgrades Ventyx Biosciences (NASDAQ:VTYX) from Perform to Outperform and announces $12 price target.
BenzingaMar 12 04:56 ET
12 Health Care Stocks Moving In Monday's Intraday Session
GainersRegencell Bioscience (NASDAQ:RGC) shares rose 130.9% to $10.39 during Monday's regular session. The company's market cap stands at $135.2 million. TC BioPharm (Holdings) (NASDAQ:TCBP) shares in
BenzingaMar 11 13:31 ET
Ventyx Biosciences Is Maintained at Buy by Canaccord Genuity
Ventyx Biosciences Is Maintained at Buy by Canaccord Genuity
Dow JonesMar 11 13:04 ET
Express News | Canaccord Genuity Maintains Buy on Ventyx Biosciences, Lowers Price Target to $16
Moomoo 24/7Mar 11 12:54 ET
ELTK, PSTX and LTRN Among Mid-day Movers
Seeking AlphaMar 11 12:49 ET
No Data
No Data